Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Algorhythm Holdings (RIME) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Algorhythm Holdings (RIME) over the last 16 years, with Q1 2025 value amounting to $4000.0.

  • Algorhythm Holdings' Asset Writedowns and Impairment fell 9603.96% to $4000.0 in Q1 2025 from the same period last year, while for Jun 2025 it was -$775000.0, marking a year-over-year change of. This contributed to the annual value of $918000.0 for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Algorhythm Holdings' Asset Writedowns and Impairment is $4000.0, which was down 9603.96% from -$880000.0 recorded in Q4 2024.
  • Algorhythm Holdings' Asset Writedowns and Impairment's 5-year high stood at $327763.0 during Q3 2022, with a 5-year trough of -$2.1 million in Q4 2023.
  • In the last 5 years, Algorhythm Holdings' Asset Writedowns and Impairment had a median value of $27000.0 in 2023 and averaged -$172036.0.
  • As far as peak fluctuations go, Algorhythm Holdings' Asset Writedowns and Impairment surged by 142047.48% in 2021, and later plummeted by 289508.98% in 2023.
  • Over the past 5 years, Algorhythm Holdings' Asset Writedowns and Impairment (Quarter) stood at $179340.0 in 2021, then tumbled by 138.72% to -$69447.0 in 2022, then plummeted by 2895.09% to -$2.1 million in 2023, then skyrocketed by 57.69% to -$880000.0 in 2024, then skyrocketed by 100.45% to $4000.0 in 2025.
  • Its Asset Writedowns and Impairment was $4000.0 in Q1 2025, compared to -$880000.0 in Q4 2024 and $101000.0 in Q1 2024.